...
首页> 外文期刊>The Journal of biological chemistry >Molecular mechanisms of centipede toxin SsTx-4 inhibition of inwardly rectifying potassium channels
【24h】

Molecular mechanisms of centipede toxin SsTx-4 inhibition of inwardly rectifying potassium channels

机译:蜈蚣毒素SSTX-4抑制内侧整流钾通道的分子机制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Inwardly rectifying potassium channels (Kirs) are important drug targets, with antagonists for the Kir1.1, Kir4.1, and pancreatic Kir6.2/SUR1 channels being potential drug candidates for treating hypertension, depression, and diabetes, respectively. However, few peptide toxins acting on Kirs are identified and their interacting mechanisms remain largely elusive yet. Herein, we showed that the centipede toxin SsTx-4 potently inhibited the Kir1.1, Kir4.1, and Kir6.2/SUR1 channels with nanomolar to submicromolar affinities and intensively studied the molecular bases for toxin–channel interactions using patch-clamp analysis and site-directed mutations. Other Kirs including Kir2.1 to 2.4, Kir4.2, and Kir7.1 were resistant to SsTx-4 treatment. Moreover, SsTx-4 inhibited the inward and outward currents of Kirs with different potencies, possibly caused by a K+ “knock-off” effect, suggesting the toxin functions as an out pore blocker physically occluding the K+-conducting pathway. This conclusion was further supported by a mutation analysis showing that M137 located in the outer vestibule of the Kir6.2/ΔC26 channel was the key residue mediating interaction with SsTx-4. On the other hand, the molecular determinants within SsTx-4 for binding these Kir channels only partially overlapped, with K13 and F44 being the common key residues. Most importantly, K11A, P15A, and Y16A mutant toxins showed improved affinity and/or selectivity toward Kir6.2, while R12A mutant toxin had increased affinity for Kir4.1. To our knowledge, SsTx-4 is the first characterized peptide toxin with Kir4.1 inhibitory activity. This study provides useful insights for engineering a Kir6.2/SUR1 channel–specific antagonist based on the SsTx-4 template molecule and may be useful in developing new antidiabetic drugs.
机译:向内矫正钾通道(KIRS)是重要的药物靶标,对于KIR1.1,KIR4.1和胰蛋白基KIR6.2 / SUR1潜在药物分别用于治疗高血压,抑郁和糖尿病的靶候选者。然而,鉴定了几次作用于基希斯的肽毒素,并且它们的相互作用机制仍然很大程度上难以捉摸。在此表明,蜈蚣毒素SSTX-4有时抑制Kir1.1,Kir4.1和Kir6.2 / Sur1通道与纳米摩尔至亚微粒的亲和力,并利用Patch-Clamp分析强烈地研究了毒素通道相互作用的分子碱基和网站定向突变。包括Kir2.1至2.4,Kir4.2和Kir7.1在内的其他基金耐受SSTX-4治疗。此外,SSTX-4抑制了KIR的内向和向外电流,具有不同的型效力,可能由K +“截止”效应引起,表明毒素用作物理遮挡K + - 导通路径的外孔阻滞剂。通过突变分析进一步支持该结论,显示位于Kir6.2 /ΔC26通道的外部前程中的M137是介导与SSTX-4相互作用的关键残留物。另一方面,SSTX-4内的分子测定剂用于结合这些KIR通道仅部分重叠,K13和F44是共同的关键残基。最重要的是,K11A,P15A和Y16A突变毒素显示出改善的亲和力和/或选择性对KIR6.2,而R12A突变体毒素对KIR4.1具有增加的亲和力。据我们所知,SSTX-4是第一个具有KIR4.1抑制活性的肽毒素。本研究提供了基于SSTX-4模板分子工程KIR6.2 / SUR1通道特异性拮抗剂的有用见解,并且可用于开发新的抗糖尿病药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号